Shares in French biotech Abivax tumbled more than 30% today, after it announced phase 3 data with ulcerative colitis (UC) candidate obefazimod that showed strong efficacy, but also cases of cancer ...

Developing new drugs and therapies is a contact sport for research sites. Investigators are on the frontlines, meeting and ...

The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

As the European Society of Cardiology Congress 2026 kicks off today, UK biopharma company Isomab has presented landmark ...

Sword Health, a digital therapeutics company that started in the physical therapy space, has acquired digital mental health ...

Pharmaceutical portfolio decision-making is facing structural pressure. Patent expirations, rising development costs, ...

Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT ...

The US FDA has green lit ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 in children weighing at least ...

After a series of bumps in the road, Roviant and Priovant Therapeutics have finally secured US approval for the once-daily oral TYK2/JAK1 inhibitor, Lisraya (brepocitinib), for adults with ...

Jazz Pharmaceuticals has been granted US approval for two combinations of its cancer drug Ziihera for people with advanced ...

While obesity may be a fast-growing cost area, it's far from the largest -- only 10% of employers surveyed put it in their ...

The ambition to build a Phase I oncology clinical development centre can be deceptively simple. The temptation is to ...